PYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES
    16.
    发明申请
    PYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES 有权
    吡啶并[2,3-d]吡嗪-2,4(1H,3H) - 衍生物

    公开(公告)号:US20160046624A1

    公开(公告)日:2016-02-18

    申请号:US14822135

    申请日:2015-08-10

    CPC classification number: C07D471/04 A61K31/519

    Abstract: This invention relates to novel Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.

    Abstract translation: 本发明涉及式(I)的新型吡啶并[2,3-d]嘧啶-2,4(1H,3H) - 二酮衍生物及其作为TRPC5调节剂的用途,含有它们的药物组合物,以及使用 与治疗TRPC5受体介导的紊乱或病症的药物相同。 R1,R2,R3和R4具有说明书中给出的含义。

    THIENO- AND FURO[2,3-d]PYRIMIDINE-2,4[1H,3H]-DIONE DERIVATIVES
    17.
    发明申请
    THIENO- AND FURO[2,3-d]PYRIMIDINE-2,4[1H,3H]-DIONE DERIVATIVES 有权
    噻吩并呋喃并[2,3-d]嘧啶-2,4 [1H,3H] - 衍生物

    公开(公告)号:US20160039841A1

    公开(公告)日:2016-02-11

    申请号:US14822018

    申请日:2015-08-10

    CPC classification number: C07D495/04 A61K31/519 C07D491/04 C07D491/048

    Abstract: This invention relates to novel Thieno- and Furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives of formula I and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. A, R1, R2, R3 and R4 have meanings given in the description.

    Abstract translation: 本发明涉及式I的新型噻吩并呋喃并[2,3-d]嘧啶-2,4 [1H,3H] - 二酮衍生物及其作为TRPC5调节剂的用途,含有它们的药物组合物,以及使用 与治疗TRPC5受体介导的紊乱或病症的药物相同。 A,R1,R2,R3和R4具有说明书中给出的含义。

    PYRROLO[3,2-d]PYRIMIDINE-2,4(3H,5H)-DIONE DERIVATIVES
    18.
    发明申请
    PYRROLO[3,2-d]PYRIMIDINE-2,4(3H,5H)-DIONE DERIVATIVES 有权
    吡咯并[3,2-d]嘧啶-2,4(3H,5H) - 衍生物

    公开(公告)号:US20160039831A1

    公开(公告)日:2016-02-11

    申请号:US14822022

    申请日:2015-08-10

    CPC classification number: C07D487/04 A61K31/519

    Abstract: This invention relates to novel Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 R4 and R5 have meanings given in the description.

    Abstract translation: 本发明涉及式(I)的新颖的吡咯并[3,2-d]嘧啶-2,4(3H,5H) - 二酮衍生物:及其作为TRPC5调节剂的用途,含有它们的药物组合物,以及使用 与治疗TRPC5受体介导的紊乱或病症的药物相同。 R1,R2,R3 R4和R5具有说明书中给出的含义。

    PYRIDO[3,4-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES
    19.
    发明申请
    PYRIDO[3,4-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES 有权
    吡咯并[3,4-d]吡嗪-2,4(1H,3H) - 衍生物

    公开(公告)号:US20160039815A1

    公开(公告)日:2016-02-11

    申请号:US14822232

    申请日:2015-08-10

    CPC classification number: C07D471/04 A61K31/519

    Abstract: This invention relates to novel Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.

    Abstract translation: 本发明涉及式(I)的新型吡啶并[3,4-d]嘧啶-2,4(1H,3H) - 二酮衍生物:及其作为TRPC5调节剂的用途,含有它们的药物组合物,以及使用 与治疗TRPC5受体介导的紊乱或病症的药物相同。 R1,R2,R3和R4具有说明书中给出的含义。

Patent Agency Ranking